-
09:35
-09:42
A tumor-resident bacterium, Comamonas testosteroni, promotes cervical cancer progression through estrogen metabolic reprogramming
-
09:42
-09:49
HPV16/18 integration drives Sp1-mediated epigenomic reprogramming to promote immune evasion in cervical cancer
-
09:49
-09:56
Prospective evaluation of ultrasensitive ddPCR and NGS for circulating tumor HPV DNA in cervical cancer
-
09:56
-10:03
The identification of plasma exosomal protein biomarkers for cervical cancer with lymph node metastasis
-
10:03
-10:10
Spatial niche characteristics and intercellular interactions in lymph node metastasis of cervical cancer: a multi-omics study
-
10:10
-10:17
Real-world treatment discontinuation patterns and outcomes of paclitaxel-cisplatin-bevacizumab in advanced or recurrent cervical cancer
-
10:17
-10:24
Clinical feasibility and prognostic determinants of immune checkpoint inhibitor rechallenge in metastatic cervical cancer: a multicenter real-world study
-
10:24
-10:31
Real-world clinical outcomes and safety of tisotumab vedotin in recurrent or metastatic cervical cancer

